Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | NNVC Invading Into VIRL and PWRM’s areas of researchNNVC Invading Into VIRL and PWRM’s areas of research
By: crwepicks ******************************************* NanoViricides, Inc. (NNVC.OB) Last: $2.15 Change: +$0.24 (+12.57%) Recent news: Anti-Dengue Nanociricides Achieve Significant Protection in Initial In Vivo Studies on Dengue Hemorrhagic Fever NanoViricides Inc. is a development stage nano-biopharmaceutical company, engages in the discovery, development, and commercialization of anti-viral therapeutics primarily in the United States. It has licenses in perpetuity to develop drugs for the treatment of human viral diseases, such as human immunodeficiency virus, Hepatitis B Virus, Hepatitis C Virus (HCV), Herpes Simplex Virus, Rabies, Influenza, and Asian Bird Flu Virus. NNVC's products under development include FluCide-I for the treatment of common influenzas and avian influenza H5N1; AviFluCide-I against H5N1, the avian influenza strain; FluCide-HP against highly pathogenic avian influenza viruses; RabiCide-I, a nanoviricide against rabies; and HCV, a Hepatitis C nanoviricide. It also provides HivCide-I, a drug project against HIV-I; HivCide-II, a targeted nanoviricide against HIV strains; and EKCCide-I, a nanoviricide drug, which indicates efficacy and safety of a drug candidate against the severe pink eye disease caused by adenoviruses called epidemic kerato-conjunctivitis. Visit: http://www.nanoviricides.com _________________________________ Virage Logic Corporation (NasdaqGM: VIRL) VIRL way up today on news of acquisition by Synopsys. Last: $11.90 Chg: +0.01(+0.08%) Vol: 267,949 Read the entire story Synopsys buys some assets of private chip technology co About VIRL: Virage Logic’s highly differentiated product portfolio includes processor solutions, interface IP solutions, embedded SRAMs and NVMs, embedded test and yield optimization solutions, logic libraries, and memory development software. As the semiconductor industry’s trusted IP partner, more than 400 foundry, IDM and fabless customers rely on Virage Logic to achieve higher performance, lower power, higher density and optimal yield, as well as shorten time-to-market and time-to-volume. Visit: http://www.viragelogic.com< /a> ___________________________________ POWER 3 MEDICAL PRODUCTS (OTC BB: PWRM.OB) Last:$0.0386 PWRM is now available for $0.0386 cents a share with an RSI creeping closer to 30 which could be interpreted as a time to buy. Since the beginning of June 2010 PWRM has been trading in a channel. Pay attention for a possible breakout. PWRM deserves to be watched very closely! A breakout could be an indicator of possible momentum. PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. Power3 Medical works with key physician scientists at major medical research and treatment centers. With access to decisive human clinical samples and superior trade secret proteomic methodologies, the Company provides solutions to pressing challenges in diagnosis and treatment of patients and has concluded research agreements, technology license agreements, and filed provisional and utility patents. Power3 is also adding additional layers of research and license agreements, patent filings, and trade secrets, as its technology and product portfolio develops, to cover: Processes - The manner in which the discoveries are made and tests developed Discoveries - Protein disease footprints, Products - Early detection tests, Biomarkers, and Drug Targets The intellectual property that Power3 has and continues to pursue today covers the product areas of breast cancer, neurodegenerative diseases, and drug resistance: The intellectual property that Power3 has and continues to pursue today covers the product areas of breast cancer, neurodegenerative diseases, and drug resistance. Visit: http://www.Power3Medical.com ******************************************* Sign-Up For Free Stock Alerts At http://crwepicks.com/ ******************************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.StockHotTips.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB) ******************************************* End
|
| |||||||||||||||||||||||||||||||||||||||
